Key result
Concentric left ventricular hypertrophy was associated with a higher prevalence of midwall fractional shortening impairment compared to eccentric hypertrophy.
Why the study?
Is left ventricular geometry associated with midwall fractional shortening impairment in hypertensive patients with LVH and LVEF >45%?
Cross-Sectional (n=1,887)
Is left ventricular geometry associated with midwall fractional shortening impairment in hypertensive patients with LVH and LVEF >45%?
In hypertensive patients with LVH and normal LVEF, midwall fractional shortening impairment is a frequent early sign of systolic dysfunction, particularly in those with concentric geometry and normal diastolic function.
Answers are grounded in this paper and cite their sources.
May warrant closer midwall assessment in concentric LVH; leaves open prognostic and therapeutic implications.
BACKGROUND: The correlation between left ventricular (LV) geometry, mass, diastolic function, and midwall fractional shortening (MFS) in hypertensive patients with left ventricular hypertrophy (LVH) is not well established owing to limited diffusion of MFS evaluation. The aim of the study was to evaluate this correlation in 1887 consecutive hypertensive patients, all affected by LVH (mean age 66 years, 924 males), with LV ejection fraction (LVEF) >45% for early detection of ventricular dysfunction rather than LVEF and diastolic function impairment. METHODS AND RESULTS: All patients underwent M-B mode echocardiography and PW-Doppler evaluation. LV geometry and mass were compared with Doppler-determined mitral flow and tissue velocities. LV geometry was eccentric (E) for 1018 subjects (53.9%) and concentric (C) for 869 (46.1%). There was no difference concerning LV diastolic dysfunction (P: n.s.) between 576 (30.6%) of the ELVH and 368 (19.4%) of the CLVH patients. The following parameters showed significant statistical differences: LV MFS impairment (P < 0.01) between 86 (4.6%) of the ELVH and 177 (9.4%) of the CLVH patients. LV MFS impairment rate was higher in 171 patients without LV diastolic dysfunction (9.1%), than in 92 patients affected (4.9%, P < 0.02). In CLVH patients, a higher prevalence of LV MFS impairment was observed in 143 without LV diastolic dysfunction (7.6%), than in 34 patients affected (1.8%, P < 0.01). In ELVH patients, a lower prevalence of LV MFS impairment was observed in 28 without diastolic dysfunction (1.5%), than in 58 patients affected (3.1%, P < 0,03). CONCLUSION: Midwall LV impairment, an independent predictor of cardiac death and morbidity in hypertensive patients, can allow early identification of patients with LV dysfunction even when LVEF or assessment of diastolic function are normal. LV MFS impairment rate is higher in CLVH patients, and even higher when considering only those CLVH patients with no diastolic dysfunction. These results suggest that the ventricular dysfunction with normal LVEF is not always due to diastolic dysfunction, but often to systolic dysfunction as assessed by MFS impairment, an important early sign of ventricular dysfunction in hypertensive patients, even when diastolic function is normal.
No takes yet. Share an insight, caveat, or question.
Palmiero et al. (2007) conducted a cross-sectional in Hypertensive left ventricular hypertrophy (n=1,887). Concentric left ventricular hypertrophy vs. Eccentric left ventricular hypertrophy was evaluated on Left ventricular midwall fractional shortening (MFS) impairment (p=<0.01). Concentric left ventricular hypertrophy was associated with a higher prevalence of midwall fractional shortening impairment compared to eccentric hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: